Mostrando 3,861 - 3,880 Resultados de 9,071 Para Buscar 'Gigean~', tiempo de consulta: 1.34s Limitar resultados
  1. 3861
  2. 3862
  3. 3863
  4. 3864
  5. 3865
  6. 3866
  7. 3867
  8. 3868
  9. 3869
  10. 3870
  11. 3871
  12. 3872
  13. 3873
  14. 3874
    “…This result for steady-state DOX C(max) is likely limited given that its efficacy is mainly AUC-driven. The immunogenicity endpoint was met, wherein LB of two-sided 95% CI of the geometric mean ratio of TNA NF(50) was >0.5 (0.78 for CIP, 0.81 for DOX). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 3875
    “…AV7909 administered IM two weeks apart was well tolerated in healthy adults. DISCLOSURES: Gideon Akintunde, Director Clinical Development, Emergent Biosolutions: Employee Bojan Drobic, Director Clinical Development, Emergent Biosolutions: Employee Lisa Bedell, Director Biostatistic, Emergent Biosolutions: Employee Lu Gan, Director Biostatistic, Emergent Biosolutions: Employee Julia Kim, Scientist Clinical Development, Emergent Biosolutions: Employee Marinda Beah, Manager Clinical Trials Development, Emergent Biosolutions: Employee Isaac Ghinai, Medical Director, Emergent Biosolutions: Employee Santiago Barona Collado, Medical Director, Emergent Biosolutions: Employee…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 3876
  17. 3877
  18. 3878
  19. 3879
  20. 3880
Herramientas de búsqueda: RSS